Rare Lymphomas

The past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clin...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Dreyling, Martin (Επιμελητής έκδοσης), Williams, Michael E. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2014.
Σειρά:Hematologic Malignancies
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 03099nam a22004695i 4500
001 978-3-642-39590-1
003 DE-He213
005 20150519184758.0
007 cr nn 008mamaa
008 140213s2014 gw | s |||| 0|eng d
020 |a 9783642395901  |9 978-3-642-39590-1 
024 7 |a 10.1007/978-3-642-39590-1  |2 doi 
040 |d GrThAP 
050 4 |a RB45 
072 7 |a MJF  |2 bicssc 
072 7 |a MED038000  |2 bisacsh 
082 0 4 |a 616.15  |2 23 
245 1 0 |a Rare Lymphomas  |h [electronic resource] /  |c edited by Martin Dreyling, Michael E. Williams. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2014. 
300 |a X, 364 p. 80 illus., 70 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Hematologic Malignancies 
505 0 |a I General:  Pathology -- Cytogenetics -- Molecular Genetics -- Signal Pathways -- II Disease-specific: T-NHL: Acute T-cell leukemia -- Anaplastic lymphoma -- Nasal/NK-cell lymphoma -- Cutaneous T-cell lymphoma -- B-NHL: Adult Burkitt -- Primary Mediastinal Lymphoma -- CNS Lymphoma -- HIV-Associated lymphoma -- Marginal Zone Lymphoma -- MALT -- MCL -- Waldenstroem -- PLL -- Llymphocyte Predominant Hodgkin -- Cutaneous B-cell lymphoma. 
520 |a The past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist.   This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe the histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity. This book will prove an excellent resource for both experienced and inexperienced practitioners. 
650 0 |a Medicine. 
650 0 |a Hematology. 
650 0 |a Oncology. 
650 1 4 |a Medicine & Public Health. 
650 2 4 |a Hematology. 
650 2 4 |a Oncology. 
700 1 |a Dreyling, Martin.  |e editor. 
700 1 |a Williams, Michael E.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783642395895 
830 0 |a Hematologic Malignancies 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-39590-1  |z Full Text via HEAL-Link 
912 |a ZDB-2-SME 
950 |a Medicine (Springer-11650)